Skip to main content
Rural Health Information Hub

Rural Health
Resources by Topic: Pharmacy and prescription drugs

Although IHS Allocated COVID-19 Testing Funds to Meet Community Needs, It Did Not Ensure That the Funds Were Always Used in Accordance with Federal Requirements
Presents results of an audit of Indian Health Service (IHS) funds for COVID-19 testing. Examines if 10 IHS Direct, Tribal, and Urban Indian Organizations (UIO) in the Great Plains Area Office allocated COVID-19 testing funds to meet community needs, the effectiveness of the funding allocation, and if the funding was used in accordance with federal requirements. Outlines recommendations to IHS, as well as IHS comments and the U.S. Department of Health and Human Service Office of the Inspector General's response.
Additional links: Report in Brief
Date: 07/2023
Type: Document
Sponsoring organization: Office of Inspector General (HHS)
view details
Rural Pharmacies Provide Multi-Faceted Value to Rural Communities
Describes the role rural pharmacies can play in the provision of healthcare in rural communities. Describes the challenges faced by rural pharmacies and efforts to address those challenges through partnerships and pharmacist training.
Author(s): Whitney Zahnd
Citation: Rural Monitor
Date: 07/2023
Type: Document
Sponsoring organization: Rural Health Information Hub
view details
Addressing the Opioid Crisis: A Look at the Evolving Landscape of Federal OUD Treatment Policies
Provides an overview of five federal policies that impacted the provision of opioid use disorder (OUD) treatments during the COVID-19 pandemic. Covers regulations related to buprenorphine medication, methadone dispensing programs, overdose prevention and reversal methods, and leveraging Medicaid for pre- and post-release from prison OUD treatment services. Discusses how state laws may limit federal efforts.
Author(s): Heather Saunders, Nirmita Panchal
Date: 07/2023
Type: Document
Sponsoring organization: KFF
view details
Oral Health Disparities Through the Lifespan: Challenges and Opportunities
Recording of a June 7, 2023, conference session on oral health disparities as part of the Centers for Medicare & Medicaid Services (CMS) Health Equity Conference. Features a presentation from the CMS Office of the Administrator comparing differences in rural and urban dental opioid prescribing to adolescent/young adult and adult Medicaid/CHIP enrollees by patient and county characteristics. Transcript available by clicking the dots above the video description, then selecting Show transcript.
Additional links: Carla Shoff, Centers for Medicare & Medicaid Services Office of the Administrator - Presentation Slides
Date: 06/2023
Type: Video/Multimedia
Sponsoring organization: Centers for Medicare and Medicaid Services
view details
MedPAC Report to the Congress: Medicare and the Health Care Delivery System, June 2023
Evaluates Medicare payment issues and provides recommendations to the U.S. Congress. Chapter 7 presents a report on the use, payment, and quality of telehealth services that Medicare pays for separately under the physician fee schedule (PFS). Also includes chapters on the cost of drugs covered under Medicare Part B, postsale rebates for prescription drugs in Medicare Part D, standardized benefits in Medicare Advantage plans, future directions for Medicare Advantage payment policy, disparities in outcomes for beneficiaries with different social risks, Medicare behavioral health services, the alignment of fee-for-service payment rates across ambulatory settings, and the evaluation of a post-acute care prospective payment system prototype.
Date: 06/2023
Type: Document
Sponsoring organization: Medicare Payment Advisory Commission
view details
Mental Health Treatment Among Children Aged 5–17 Years: United States, 2021
Reports on U.S. children between the ages of 5 and 17 who had counseling or therapy from a mental health professional or took prescription medication for mental health in the past 12 months. Includes data for children living in nonmetropolitan areas, small or medium metro areas, and large metro areas.
Author(s): Benjamin Zablotsky, Amanda E. Ng
Date: 06/2023
Type: Document
Sponsoring organization: National Center for Health Statistics
view details
Indiana's Contraceptive Care Workforce: Current State and Opportunities
Provides an overview of contraceptive care workers in Indiana, such as primary care, maternity care, and pharmacist providers. Includes a county-level map showing location of pharmacists as well as counties that are Primary Care Health Professional Shortage Areas (PC HPSAs) and that do or do not have sufficient Maternity Care Practitioner (MCP) Capacity.
Author(s): Becky Boustani, Courtney Medlock, Hannah Maxey
Date: 06/2023
Type: Document
Sponsoring organization: Bowen Center for Health Workforce Research and Policy
view details
340B Drug Discount Program: Information about Hospitals That Received an Eligibility Exception as a Result of COVID-19
Provides an overview of a provision of the Consolidated Appropriations Act, 2022, that allowed hospitals to request an exception to the disproportionate share hospital (DSH) percentage eligibility requirement if they were unable to meet it due to the COVID-19 pandemic. Explores the exception process and provides information on hospitals that received the exception. Discusses the amount of 340B drug purchases and discounts that excepted hospitals indicated they had in 2020 and 2021; the extent to which excepted hospitals indicated providing discounts on 340B drugs to low-income, uninsured patients; and results of the Health Resources and Services Administration's audits and oversight activities to assess program compliance.
Additional links: Full Report
Date: 05/2023
Type: Document
Sponsoring organization: Government Accountability Office
view details
Medication for Opioid Use Disorder During Pregnancy — Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014–2021
Describes a surveillance network of seven clinical sites focused on the use of medication for opioid use disorder (MOUD) during pregnancy. Initial report is limited to selected demographic characteristics of pregnant persons overall and by MOUD treatment status, including data for urban and rural areas.
Author(s): Kathryn Miele, Shin Y. Kim, Rachelle Jones, et al.
Citation: MMWR Surveillance Summaries, 72(3), 1-14
Date: 05/2023
Type: Document
Sponsoring organization: Centers for Disease Control and Prevention
view details
Promoting Disposal of Left-Over Opioids After Surgery in Rural Communities: A Qualitative Description Study
Evaluates factors influencing opioid disposal after surgery among 30 patients in rural communities in Arizona, Idaho, Montana, Nevada, Oregon, Utah, and Wyoming. Identifies barriers and facilitators of opioid disposal, including awareness and engagement, perceived risks of keeping left-over opioids, convenience of disposal, and motivators of intentional nondisposal.
Author(s): Lyen C. Huang, Jordan E. Johnson, Josh Bleicher, et al.
Citation: Health Education & Behavior, 50(2), 281-289
Date: 04/2023
Type: Document
view details